Navigation Links
Access Pharmaceuticals Presents ProLindac(TM) Data at the AACR-NCI-EORTC Symposium 2008
Date:10/21/2008

- ProLindac Is Safe And Active in Recurrent Ovarian Cancer; Unique Design Simulates 4-Day Continuous Infusion -

DALLAS, Oct. 21 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today that three posters describing significant recent results of the company's proprietary polymer DACH platinum prodrug, ProLindac, in clinical and preclinical studies are being presented this week at a major international oncology conference held in Geneva, Switzerland.

The clinical poster highlights results from the multi-center Phase 2 recurrent ovarian cancer trial in France where the level of anti-cancer activity of ProLindac in a heavily-pretreated patient population compares favorably to previously published results of single agent oxaliplatin in patients that had less pretreatment. These promising efficacy results were obtained without significant toxicity or other significant side-effects. The two preclinical posters, describing studies performed by Access collaborators at prominent Institutes in France, demonstrate the potential benefits of ProLindac over current platinum therapies: one highlights the observation that ProLindac uses albumin as a carrier, slowing blood clearance, which provides for a sustained tumor exposure to platinum. The other poster highlights that the antiproliferative effects of ProLindac are associated with an increase in expression of p21, a gene associated with cell cycle control.

"The latest results from our clinical study in advanced ovarian cancer patients continue to demonstrate that ProLindac is active in ovarian cancer with mild side-effects," stated David P. Nowotnik, Access' Senior Vice President Research and Development. "The two preclinical posters show that, mechanistically, ProLindac is similar to the approved DACH platinum compound, oxaliplatin, while benefiting from Access' proprietary polymer targeting technology. Our unique design enables targeted delivery of higher lev
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Bend Research Offers Broad Access to Drug-Delivery Solutions
2. Concentric Medical Launches Distal Access Catheter
3. Bumrungrad International Hospital Makes Treatment Costs Available to Public - Bumrungrad International Offers Free Online Access to Actual Costs of 45 Procedures
4. Access to Physicians Is Consumers Highest Priority When Choosing a Health Plan, According to New Study
5. SAGE-Hindawi launch new open-access journal in dental biomechanics
6. Proposed Assisted Living Regulations Would Allow Facilities to Rent Inaccessible Rooms to Persons Who Use Wheelchairs or Walkers
7. ICERx.org Activated to Provide Emergency Access to Prescription Medication Information for Hurricane Ike Evacuees
8. New Vascular Access Medical Devices Launched by Navilyst Medical
9. Gulf Coast Dialysis Caregivers, Volunteers Brace for Hurricane Ike; Prepare to Maintain Power, Continued Access for Patients to Life-Saving Treatment
10. Young African-American Males Face Mental Health Crisis; Experts Call For New Treatment Strategies and Better Access to Care
11. Autovan Donates Wheelchair-Accessible Van; Brings Greater Mobility to Facility in Rochester, New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... 2015 , ... Denver-based SlimGenics Weight Control Centers, the leader ... 14 on ColoradoBiz magazine’s Top 100 Woman-Owned Companies list. ColoradoBiz compiles the exclusive ... award identifies outstanding woman-owned businesses that demonstrate excellence and success in the industry ...
(Date:7/1/2015)... ... 2015 , ... With all final regulatory approvals in place ... N.Y., is now a member of national system Trinity Health, effective immediately. ... committed to delivering high-value care, said Richard J. Gilfillan, M.D., president and CEO, ...
(Date:7/1/2015)... ... 01, 2015 , ... For decades, researchers in the genetics field have theorized ... brain, never changing after development in the womb. Now, researchers from the Icahn School ... cells throughout life – a process which helps to switch genes on and off. ...
(Date:7/1/2015)... ... 01, 2015 , ... Ormco Corporation, a leading manufacturer and ... Smile for a Lifetime Foundation (S4L) fundraising event held at the 14th Annual ... S4L in its mission to provide free quality orthodontic care to individuals with ...
(Date:7/1/2015)... ... July 01, 2015 , ... The Collaborative for Children and ... Community Trust. The grant will allow CCF to improve quality of care and save ... was formed to respond to many changes in New York’s Medicaid system. Experts agree ...
Breaking Medicine News(10 mins):Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 2Health News:ColoradoBiz Magazine Names SlimGenics #14 on Top 100 Woman-Owned Companies List 3Health News:St. Joseph’s Health Now a Member of Trinity Health 2Health News:St. Joseph’s Health Now a Member of Trinity Health 3Health News:St. Joseph’s Health Now a Member of Trinity Health 4Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 2Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 3Health News:Mount Sinai Researchers Discover New Epigenetic Mechanism in Brain Cells 4Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 2Health News:The Forum Fundraiser Raises $80,000 for the Smile for a Lifetime Foundation 3Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3
... 02, 2009 The antiepileptic drug vigabatrin (VGB) has been ... special form of epilepsy in infants, called infantile spasm. However, ... has been shown to cause a permanent narrowing of visual ... exposed at school age or later. A new study published ...
... U.S. Ambassador to the United Republic of Tanzania, joins Malaria ... No More Policy Center in Washington, DC, the non-profit organization ... fight against malaria in Africa to his new role at ... advocacy work to engage policymakers in the race to save ...
... given awayFORT WORTH, Texas, Feb. 2 ... USA announces the launch of the second season ... 26, 2009, Marinela USA consumers can collect one ... specially marked boxes of Barritas Fresa, Barritas Pina, ...
... and only multi-module training program devoted exclusively to whiplash ... Stutzman, local Doctor of Chiropractic practicing in Paoli, PA ... specifically to whiplash and brain injury traumatology. The ... prestigious Spine Research Institute of San Diego . ...
... Danaher Corporation (NYSE: DHR ) announced ... L. Comas will be presenting at the Barclays Capital ... 9, 2009 at 1:35 p.m. EST. The audio will ... of the webcast will be available for one week ...
... Digirad Corporation (Nasdaq: DRAD ), a ... equipment leasing services that improve patient care while driving ... the assets related to three northern California service hub ... Fe, Calif.-based MD Office Solutions calls for the sale ...
Cached Medicine News:Health News:Controversial medication may decrease spasms for infants with epilepsy 2Health News:Recent U.S. Ambassador to Tanzania Mark Green Named Managing Director of Malaria No More Policy Center 2Health News:Marinela USA(R) Recharges ZumbAtomic for Second Season 2Health News:Local Chiropractic Doctor Graduates from Elite Whiplash Trauma Training Program Led by International Scientific Authority, Dr. Arthur Croft 2Health News:Local Chiropractic Doctor Graduates from Elite Whiplash Trauma Training Program Led by International Scientific Authority, Dr. Arthur Croft 3Health News:Digirad Corporation Sells Northern California Service Hubs 2
(Date:7/1/2015)... 2015 Precyse, a leader in health information ... as part of its long term growth plan, the ... by investment firm Pamplona Capital Management (Pamplona).  Precyse,s board ... Partners and NewSpring Capital, have approved this corporate transaction. ... 5,000 healthcare facilities and systems across the ...
(Date:7/1/2015)... Research and Markets( ... "2015 Strategies in the Home/Self Testing Market" ... new 175-page report provides analysis of the major ... meters), pregnancy, ovulation, and occult blood. The report ... and competitive profiles. The growing economic ...
(Date:7/1/2015)... 2015 Dynatronics Corporation (the "Company") (NASDAQ: ... rehabilitation and physical therapy products, announced today that ... led by affiliates of Prettybrook Partners LLC (collectively, ... the healthcare industry. The financing provides Dynatronics with ... potential strategic acquisitions.  "We enthusiastically ...
Breaking Medicine Technology:Precyse Enters into Acquisition Agreement with Pamplona Capital Management 2Precyse Enters into Acquisition Agreement with Pamplona Capital Management 32015 Strategies in the Home/Self Testing Market 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3
... YORK, Aug. 31 /PRNewswire/ Reportlinker.com announces that a ... catalogue: Hormone Replacement Therapy in ... 2017 http://www.reportlinker.com/p0254468/Hormone-Replacement-Therapy-in-Menopause---Pipeline-Assessment-and-Market-Forecasts-to-2017.html ... Assessment and Market Forecasts to 2017 ...
... 31 Reportlinker.com announces that a new market ... The Outlook for Pharmaceuticals In The ... http://www.reportlinker.com/p0285781/The-Outlook-for-Pharmaceuticals-In-The-Middle-East-And-North-Africa-To-2015.html ... social and demographic development is making the pharmaceutical ...
Cached Medicine Technology:Reportlinker Adds Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017 2Reportlinker Adds Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017 3Reportlinker Adds Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017 4Reportlinker Adds Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017 5Reportlinker Adds Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017 6Reportlinker Adds Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017 7Reportlinker Adds Hormone Replacement Therapy in Menopause - Pipeline Assessment and Market Forecasts to 2017 8Reportlinker Adds The Outlook for Pharmaceuticals In The Middle East And North Africa To 2015 2Reportlinker Adds The Outlook for Pharmaceuticals In The Middle East And North Africa To 2015 3Reportlinker Adds The Outlook for Pharmaceuticals In The Middle East And North Africa To 2015 4Reportlinker Adds The Outlook for Pharmaceuticals In The Middle East And North Africa To 2015 5Reportlinker Adds The Outlook for Pharmaceuticals In The Middle East And North Africa To 2015 6Reportlinker Adds The Outlook for Pharmaceuticals In The Middle East And North Africa To 2015 7Reportlinker Adds The Outlook for Pharmaceuticals In The Middle East And North Africa To 2015 8Reportlinker Adds The Outlook for Pharmaceuticals In The Middle East And North Africa To 2015 9Reportlinker Adds The Outlook for Pharmaceuticals In The Middle East And North Africa To 2015 10Reportlinker Adds The Outlook for Pharmaceuticals In The Middle East And North Africa To 2015 11Reportlinker Adds The Outlook for Pharmaceuticals In The Middle East And North Africa To 2015 12Reportlinker Adds The Outlook for Pharmaceuticals In The Middle East And North Africa To 2015 13Reportlinker Adds The Outlook for Pharmaceuticals In The Middle East And North Africa To 2015 14
S-ROM acetabular cups provide a variety of geometrical options to help address many anatomical situations and defects....
S-ROM acetabular cups provide a variety of geometrical options to help address many anatomical situations and defects....
The Trident PSL Acetabular Shells are designed to maximize fixation in the peripheral lunate region of the acetabulum....
The Trident ceramic acetabular system provides several important benefits and meets greater demands of younger, more active patients....
Medicine Products: